Decrease of cellular cAMP levels in response to a concentration range of melatonin treatments. by Cathryn S. D. Maienza (20629929)

Disturbance of coherent behaviour leads to a decrease in information transfer. by Hannah Zoller (19688084)

Knockdown of ATP2C1 results in a minor decrease of [Ca²⁺] in WPB. by Julian Terglane (12975565)

Subjects:

Wnt signaling decreases the recruitment of RAB8a to basal bodies. by Cheng Yuan (160315)

Lens profiles as Ez (orange lines) force was increased and Az and Pz (green lines) forces were decreased. by Ronald A. Schachar (16674576)

Expression of lipid biosynthetic genes is decreased with polyamine depletion. by Yazmin E. Cruz-Pulido (20285238)

Apoptosis inhibitor prevented the decrease of IIL ESP-induced TJs expression and alleviated barrier disruption of Caco-2 monolayer. by Qi Qi Lu (17721401)

Subjects:

Penalty conversions yield large practical decreases, but robustness and generalizability of result are limited by data quality and sample selection. by Ryan J. Treves (13527735)

Juvenile demyelination leads to a substantial decrease in potassium currents in PV interneurons of the PFC. by Sara Hijazi (21656615)

“…Scale: 500 pA, 100 ms. <b>B</b>. I–V curves showing a significant decrease in Kv amplitude in PV interneurons from mice that underwent juvenile demyelination. …”

nsP4-C483Y or Q192L mutations decrease sensitivity to 4′-FlU. by Peiqi Yin (6533747)

Enhancing Aromaticity of Alkenylbenzenes May Decrease Their Metabolic Activation and Reduce Their Potential Cytotoxicity: Lessons Learnt from the Investigation of Myristicin and El... by Guode Zhao (7307867)

Average Gait Speed (A), Cadence (B), Step Length (C), and Walk Ratio (D) across Terrains; Violin plots with individual participant data of A) gait speed, B) cadence, C) average ste... by Benjamin S. Killen (22766029)

High-Temperature Resistance, Lightweight, and Thermally Insulating Silica Aerogel via Doping Hollow Silica Nanoparticles by Mingyang Yang (1405321)

“…Furthermore, at 1100 °C, thermal conductivity decreased by 34.4%, and the density was only 242 kg/m³, the lowest density among SiO₂-based aerogel composites. …”

High-Temperature Resistance, Lightweight, and Thermally Insulating Silica Aerogel via Doping Hollow Silica Nanoparticles by Mingyang Yang (1405321)

“…Furthermore, at 1100 °C, thermal conductivity decreased by 34.4%, and the density was only 242 kg/m³, the lowest density among SiO₂-based aerogel composites. …”

High-Temperature Resistance, Lightweight, and Thermally Insulating Silica Aerogel via Doping Hollow Silica Nanoparticles by Mingyang Yang (1405321)

“…Furthermore, at 1100 °C, thermal conductivity decreased by 34.4%, and the density was only 242 kg/m³, the lowest density among SiO₂-based aerogel composites. …”

High-Temperature Resistance, Lightweight, and Thermally Insulating Silica Aerogel via Doping Hollow Silica Nanoparticles by Mingyang Yang (1405321)

“…Furthermore, at 1100 °C, thermal conductivity decreased by 34.4%, and the density was only 242 kg/m³, the lowest density among SiO₂-based aerogel composites. …”

High-Temperature Resistance, Lightweight, and Thermally Insulating Silica Aerogel via Doping Hollow Silica Nanoparticles by Mingyang Yang (1405321)

“…Furthermore, at 1100 °C, thermal conductivity decreased by 34.4%, and the density was only 242 kg/m³, the lowest density among SiO₂-based aerogel composites. …”

High-Temperature Resistance, Lightweight, and Thermally Insulating Silica Aerogel via Doping Hollow Silica Nanoparticles by Mingyang Yang (1405321)

“…Furthermore, at 1100 °C, thermal conductivity decreased by 34.4%, and the density was only 242 kg/m³, the lowest density among SiO₂-based aerogel composites. …”

Creep failure mode and sketch map of step-step fractured rock. by Dengke Yang (842532)

Real-world mepolizumab treatment in patients with severe asthma decreased exacerbations, oral corticosteroid use, and healthcare resource utilization and costs over 4 years: a retr... by Wendy C. Moore (10682686)

“…This study evaluated the real-world impact of mepolizumab treatment in patients with severe asthma over a 4-year follow-up period.</p> <p>This was a retrospective cohort study of patients with asthma initiating mepolizumab (index date: first claim, November 2015–September 2019) using the Merative MarketScan Commercial and Medicare Databases. …”